XBiotech XBIT
NASDAQ XBIT
$2.02 +0.02 (+1.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

XBiotech (XBIT) EBIT Margin (2020 - 2022)

Updated

XBiotech's EBIT Margin came in at -860.10% for FY2022, down 723.74 percentage points from -136.36% in FY2021.

Analysis

XBiotech (XBIT) EBIT Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put EBIT Margin at -136.36% in FY2021 (-94.82 pp) and -41.54% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 28.21%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 37.86%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 20.57%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -133.21%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 28.37%
10 XBiotech 61.59 Mn -473.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -380.30%
Jun 30, 2022 -790.46%
Mar 31, 2022 -1,569.00%
Dec 31, 2021 -159.84%
Sep 30, 2021 -82.56%
Jun 30, 2021 -234.36%
Mar 31, 2021 -73.26%
Dec 31, 2020 -93.41%
Sep 30, 2020 -44.27%
Jun 30, 2020 -42.03%
Mar 31, 2020 -17.12%
API Access

XBiotech EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY